Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Strides Pharma Science Limited
  6. Financials
    532531   INE939A01011

STRIDES PHARMA SCIENCE LIMITED

(532531)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization1 59 88942 30328 85469 441--
Entreprise Value (EV)1 78 35064 93843 62082 49383 11879 446
P/E ratio 9,07x13,0x79,3x31,5x19,5x13,9x
Yield 0,67%0,64%4,35%0,94%0,58%0,66%
Capitalization / Revenue 2,11x1,40x1,05x2,12x1,83x1,61x
EV / Revenue 2,76x2,16x1,59x2,51x2,19x1,84x
EV / EBITDA 16,0x14,3x8,16x12,7x11,2x8,92x
Price to Book 2,44x1,60x1,14x2,54x2,25x1,97x
Nbr of stocks (in thousands) 89 50089 54989 56589 717--
Reference price (INR) 669472322774774774
Announcement Date 05/18/201805/10/201905/20/2020---
1 INR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales1 28 39430 11727 52032 80737 97343 128
EBITDA1 4 9064 5485 3476 4827 4068 911
Operating profit (EBIT)1 3 3662 8293 6104 3555 1986 387
Operating Margin 11,9%9,39%13,1%13,3%13,7%14,8%
Pre-Tax Profit (EBT)1 8001 2041 6192 8204 1465 786
Net income1 6 6053 2463642 3483 5565 127
Net margin 23,3%10,8%1,32%7,16%9,37%11,9%
EPS2 73,836,24,0624,639,755,7
Dividend per Share2 4,503,0014,07,254,465,14
Announcement Date 05/18/201805/10/201905/20/2020---
1 INR in Million
2 INR
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3
Net sales1 7 1517 3246 1866 9928 1208 536
EBITDA1 1 5061 8088371 2891 6381 776
Operating profit (EBIT)1 --3846471 1711 300
Operating Margin --6,20%9,25%14,4%15,2%
Pre-Tax Profit (EBT)1 1 6171 270-1 7314429441 065
Net income1 1 427939-2 039385660729
Net margin 20,0%12,8%-33,0%5,51%8,13%8,53%
EPS ------
Dividend per Share ------
Announcement Date 10/25/201901/30/202005/20/2020---
1 INR in Million
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt1 18 46122 63514 76613 05213 67710 005
Net Cash position1 ------
Leverage (Debt / EBITDA) 3,76x4,98x2,76x2,01x1,85x1,12x
Free Cash Flow1 -2 156-2 6905481 3583 2266 941
ROE (Net Profit / Equities) 3,41%12,7%1,41%8,39%11,8%14,4%
Shareholders' equity1 193 89125 56025 88027 98930 11335 565
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 274296282305344392
Cash Flow per Share2 48,249,064,347,960,871,6
Capex1 4 0263 2911 5002 4461 4901 703
Capex / Sales 14,2%10,9%5,45%7,46%3,92%3,95%
Announcement Date 05/18/201805/10/201905/20/2020---
1 INR in Million
2 INR
Key data
Capitalization (INR) 69 441 084 936
Capitalization (USD) 935 152 861
Net sales (INR) 27 519 700 000
Net sales (USD) 370 662 839
Number of employees 2 969
Sales / Employee (INR) 9 269 013
Sales / Employee (USD) 124 844
Free-Float 81,2%
Free-Float capitalization (INR) 56 389 071 078
Free-Float capitalization (USD) 759 383 313
Avg. Exchange 20 sessions (INR) 45 589 394
Avg. Exchange 20 sessions (USD) 614 044
Average Daily Capital Traded 0,07%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA